Jpmorgan Chase & CO Lemaitre Vascular Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 101,059 shares of LMAT stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,059
Previous 128,383
21.28%
Holding current value
$10.9 Million
Previous $10.6 Million
11.13%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LMAT
# of Institutions
291Shares Held
20.5MCall Options Held
5.2KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$375 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.98MShares$214 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$170 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.16MShares$126 Million1.93% of portfolio
-
Geneva Capital Management LLC878KShares$94.8 Million1.39% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.37B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...